SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for ChronoScale Holdings Corp (CHRN) (CIK 0001549084) (CHRN) — Jul 21, 2014

ChronoScale Holdings Corp (CHRN) (CIK 0001549084)
Date: July 21, 2014 · CIK: 0001549084 · Accession: 0000000000-14-036658

AI Filing Summary & Sentiment

File numbers found in text: 333-181229

Date
July 21, 2014
Author
/s/ Jay Ingram
Form
UPLOAD
Company
ChronoScale Holdings Corp (CHRN) (CIK 0001549084)

Letter

July 21, 2014 Via E -mail Nathan Harding Chief Executive Officer Ekso Bionics Holdings, Inc. 1414 Harbour Way South, Suite 1201 Richmond, California 94804

Re: Ekso Bionics Holdings, Inc. Form 8-K Filed January 23, 2014 File No. 333-181229

Dear Mr. Harding :

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Jay Ingram

Show Raw Text
July 21, 2014

Via E -mail
Nathan Harding
Chief Executive Officer
Ekso Bionics Holdings, Inc.
1414 Harbour Way South, Suite 1201
Richmond, California 94804

Re: Ekso  Bionics Holdings, Inc.
 Form 8-K
Filed January 23, 2014
File No. 333-181229

Dear Mr. Harding :

We have completed our review of your filing.  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the  Commission from taking
any action with respect to the company or the filing  and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing  to be certain that the filing include s the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Jay Ingram

Jay Ingram
Legal Branch Chief

cc: Michelle L. Basil ( via e -mail)
 Nutter McClennen & Fish LLP